us en false false Default
Skip directly to Accessibility Notice

VanEck Announces CNXT ETF Name Change

Media Contact

Ryan Graham
JConnelly
862-777-4274
[email protected]

NEW YORK, NY (April 21, 2026)VanEck today announced that the name of the VanEck ChiNext ETF will be changed to the VanEck ChiNext Innovators ETF, effective May 1, 2026.

The ETF will continue to trade on NYSE under the ticker CNXT, which will remain unchanged.

The name change is intended to better reflect the opportunity set of the ChiNext Index, which the ETF seeks to replicate. The Index seeks to track a dynamic segment of China’s equity market, with a focus on innovative, growth-oriented companies across sectors such as technology, healthcare and advanced manufacturing.

There will be no changes to the Fund’s investment objective, investment strategy, or portfolio management team as a result of the name change. The Fund will continue to seek to replicate as closely as possible, before fees and expenses, the price and yield performance of the ChiNext Index.

For more information about CNXT, please visit vaneck.com/cnxt.

About VanEck

VanEck has a history of looking beyond the financial markets to identify trends that are likely to create impactful investment opportunities. We were one of the first U.S. asset managers to offer investors access to international markets. This set the tone for the firm’s drive to identify asset classes and trends – including gold investing in 1968, emerging markets in 1993, and exchange traded funds in 2006 – that subsequently shaped the investment management industry.

Today, VanEck offers active and passive strategies with compelling exposures supported by well-designed investment processes. As of March 31, 2026, VanEck managed approximately $199.1 billion in assets, including mutual funds, ETFs and institutional accounts. The firm’s capabilities range from core investment opportunities to more specialized exposures to enhance portfolio diversification. Our actively managed strategies are fueled by in-depth, bottom-up research and security selection from portfolio managers with direct experience in the sectors and regions in which they invest. Investability, liquidity, diversity, and transparency are key to the experienced decision-making around market and index selection underlying VanEck’s passive strategies.

Since our founding in 1955, putting our clients’ interests first, in all market environments, has been at the heart of the firm’s mission.

Important Disclosures

This is not an offer to buy or sell, or a recommendation to buy or sell any of the securities, financial instruments or digital assets mentioned herein. The information presented does not involve the rendering of personalized investment, financial, legal, tax advice, or any call to action. Certain statements contained herein may constitute projections, forecasts and other forward-looking statements, which do not reflect actual results, are for illustrative purposes only, are valid as of the date of this communication, and are subject to change without notice. Actual future performance of any assets or industries mentioned are unknown. Information provided by third party sources are believed to be reliable and have not been independently verified for accuracy or completeness and cannot be guaranteed. VanEck does not guarantee the accuracy of third-party data. The information herein represents the opinion of the author(s), but not necessarily those of VanEck or its other employees.

An investment in the Fund may be subject to risks which include, but are not limited to, risks related to the Fund’s principal investment strategies, health care sector, industrials sector, information technology sector, financials sector, special risk considerations of investing in China and Chinese-issued A-shares, ChiNext Market, Stock Connect, PRC tax, foreign securities, emerging market issuers, foreign currency, medium-capitalization companies, cash transactions, equity securities, market, operational, index tracking, authorized participant concentration, no guarantee of active trading market, trading issues, passive management, fund shares trading, premium/discount, liquidity of fund shares, non-diversification, index-related concentration and high portfolio turnover risks, all of which may adversely affect the Fund. Emerging market issuers and foreign securities may be subject to securities markets, political and economic, investment and repatriation restrictions, different rules and regulations, less publicly available financial information, foreign currency and exchange rates, operational and settlement, and corporate and securities laws risks. Medium-capitalization companies may be subject to elevated risks. Investments in China may also be subject to risks which include political and economic, inflation, tax changes, nationalization and expropriation, Hong Kong policy, Chinese securities markets, less stringent disclosure, regulatory standards, and publicly available information on Chinese issuers, and Chinese corporate and securities law risks Investments in Chinese-issued A-shares may also be subject to risks related to investment and repatriation restrictions, loss of favorable U.S. tax treatment, tax on retained income and gains, foreign exchange control, custody risks, foreign currency considerations, and China-related index tracking risks.

ChiNext Index: the 100 largest and most liquid stocks listed and trading on the ChiNext Market of the Shenzhen Stock Exchange. The ChiNext Index is comprised of A-shares.

Investing involves substantial risk and high volatility, including possible loss of principal. An investor should consider the investment objective, risks, charges and expenses of a Fund carefully before investing. To obtain a prospectus and summary prospectus, which contain this and other information, call 800.826.2333 or visit vaneck.com. Please read the prospectus and summary prospectus carefully before investing.

© Van Eck Securities Corporation, Distributor, a wholly owned subsidiary of Van Eck Associates Corporation.
666 Third Avenue, New York, NY 10017
Phone: 800.826.2333
Email: [email protected]